INSYS Therapeutics Inc. (INSY)

0.30
0.01 4.52
OTC : Health Technology
Prev Close 0.29
Open 0.28
Day Low/High 0.28 / 0.32
52 Wk Low/High 0.14 / 11.65
Volume 1.09M
Avg Volume 3.70M
Exchange OTC
Shares Outstanding 74.57M
Market Cap 21.71M
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
Weak On High Volume: Insys Therapeutics (INSY)

Weak On High Volume: Insys Therapeutics (INSY)

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a weak on high relative volume candidate

Strong On High Relative Volume: Insys Therapeutics (INSY)

Strong On High Relative Volume: Insys Therapeutics (INSY)

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a strong on high relative volume candidate

Perilous Reversal Stock: Insys Therapeutics (INSY)

Perilous Reversal Stock: Insys Therapeutics (INSY)

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "perilous reversal" (up big yesterday but down big today) candidate

5 Stocks Jumping on Unusual Volume

5 Stocks Jumping on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report bullish earnings today.

UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors Of Class Action Against INSYS Therapeutics, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of July 14, 2014

UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors Of Class Action Against INSYS Therapeutics, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of July 14, 2014

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of investors who purchased INSYS Therapeutics, Inc.

INSYS Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

INSYS Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action...

Insys Therapeutics (INSY) In A Perilous Reversal

Insys Therapeutics (INSY) In A Perilous Reversal

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "perilous reversal" (up big yesterday but down big today) candidate

INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of...

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

Cohen Milstein Sellers & Toll PLLC Announces The Investigation Of Insys Therapeutics, Inc.

Cohen Milstein Sellers & Toll PLLC Announces The Investigation Of Insys Therapeutics, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Insys Therapeutics, Inc.

INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Those With Losses Exceeding $100,000 From Investment In INSYS Therapeutics, Inc. Are Encouraged To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of...

4 Stocks Spiking on Big Volume

4 Stocks Spiking on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Insider Trading Alert - ARCB, RFMD And INSY Traded By Insiders

Insider Trading Alert - ARCB, RFMD And INSY Traded By Insiders

Stocks with insider trader activity include ARCB, RFMD and INSY

Why Insys Therapeutics (INSY) Stock Is Plunging Today

Why Insys Therapeutics (INSY) Stock Is Plunging Today

Insys Therapeutics (INSY) continued to plunge Wednesday after the company announced first-quarter results that came up short of analysts' expectations.

3 Stocks Underperforming Today In The Drugs Industry

3 Stocks Underperforming Today In The Drugs Industry

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Why Insys Therapeutics (INSY) Stock Is Plunging Today

Why Insys Therapeutics (INSY) Stock Is Plunging Today

Insys Therapeutics (INSY) continued to plunge Monday after Friday's report from a Michigan local news site that a doctor had allegedly committed fraud in prescribing the company's drug Subsys.

Insys Therapeutics Continues Slide After Doctor Charged With Fraud

Insys Therapeutics Continues Slide After Doctor Charged With Fraud

Shares of Insys Therapeutics (INSY) are tumbling for a second straight session following a report of a Michigan doctor being charged with allegedly prescribing the company's Subsys painkiller to people who did not need it.

Today's Perilous Reversal Stock: Insys Therapeutics (INSY)

Today's Perilous Reversal Stock: Insys Therapeutics (INSY)

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "perilous reversal" (up big yesterday but down big today) candidate

Insys Therapeutics is Now Oversold (INSY)

Insys Therapeutics is Now Oversold (INSY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

'Mad Money' Lightning Round: Marathon Petroleum's For Me

'Mad Money' Lightning Round: Marathon Petroleum's For Me

Cramer said to wait on Rite Aid, sell Infoblox and don't gamble on Wynn Resorts or Las Vegas Sands right now.

Jim Cramer's 'Mad Money' Recap: Wall Street Is Confused

Jim Cramer's 'Mad Money' Recap: Wall Street Is Confused

Cramer says the market is so full of confusing cross-currents it has him wondering if there's something big around the corner.

Insys Therapeutics (INSY) Showing Signs Of A Dead Cat Bounce Today

Insys Therapeutics (INSY) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "dead cat bounce" (down big yesterday but up big today) candidate

Insider Trading Alert - INSY, RAI And ACGL Traded By Insiders

Insider Trading Alert - INSY, RAI And ACGL Traded By Insiders

Stocks with insider trader activity include INSY, RAI and ACGL

Commit To Purchase Insys Therapeutics At $45, Earn 25.4% Annualized Using Options

Commit To Purchase Insys Therapeutics At $45, Earn 25.4% Annualized Using Options

Investors eyeing a purchase of Insys Therapeutics stock, but cautious about paying the going market price of $57.67/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $45 strike, which has a bid at the time of this writing of $5.60.

SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 In Losses From Investment In Insys Therapeutics, Inc. To Contact Brower Piven Before The February 14, 2014 Lead Plaintiff Deadline

SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 In Losses From Investment In Insys Therapeutics, Inc. To Contact Brower Piven Before The February 14, 2014 Lead Plaintiff Deadline

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of purchasers of Insys Therapeutics, Inc.